Search

everythinglearnresearchcommunity

for

Search:↓

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

New therapies are being developed that target integrin pathways to treat various diseases.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Targeting Vδ1+T-cells may help treat alopecia areata.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.